{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:52:03Z","timestamp":1791867123757,"version":"4.3.4"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2403,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      Non-alcoholic fatty liver disease (NAFLD) is one of the most common forms of chronic liver disease, with a prevalence ranging from 10% to 30%. The use of thyroid hormone receptor (TR) agonists for the treatment of NAFLD has not been considered viable because thyroid hormones increase free fatty acid (FFA) flux from the periphery to the liver, induce hepatic lipogenesis, and therefore could potentially cause steatosis. MB07811 is an orally active HepDirect prodrug of MB07344, a liver-targeted TR-\u03b2 agonist. The purpose of these studies was to assess the effects of MB07811 on whole body and liver lipid metabolism of normal rodents and rodent models of hepatic steatosis. In the current studies, MB07811 markedly reduced hepatic steatosis as well as reduced plasma FFA and triglycerides. In contrast to MB07811, T\n                      <jats:sub>3<\/jats:sub>\n                      induced adipocyte lipolysis\n                      <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      and had a diminished ability to decrease hepatic steatosis. This suggests the influx of FFA from the periphery to the liver may partially counteract the antisteatotic activity of T\n                      <jats:sub>3<\/jats:sub>\n                      . Clearance of liver lipids by MB07811 results from accelerated hepatic fatty acid oxidation, a known consequence of hepatic TR activation, as reflected by increased hepatic mitochondrial respiration rates, changes in hepatic gene expression, and increased plasma acyl-carnitine levels. Transaminase levels remained unchanged, or were reduced, and no evidence for liver fibrosis or other histological liver damage was observed after treatment with MB07811 for up to 10 weeks. Additionally, MB07811, unlike T\n                      <jats:sub>3<\/jats:sub>\n                      , did not increase heart weight or decrease pituitary thyroid-stimulating hormone beta (TSH\u03b2) expression.\n                      <jats:italic toggle=\"yes\">Conclusion:<\/jats:italic>\n                      MB07811 represents a novel class of liver-targeted TR agonists with beneficial low-density lipoprotein cholesterol-lowering properties that may provide additional therapeutic benefit to hyperlipidemic patients with concomitant NAFLD. (Hepatology 2009.)\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.22572","type":"journal-article","created":{"date-parts":[[2008,8,13]],"date-time":"2008-08-13T11:57:17Z","timestamp":1218628637000},"page":"407-417","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":186,"title":["Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist #"],"prefix":"10.1097","volume":"49","author":[{"given":"Edward E.","family":"Cable","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia D.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey W.","family":"Stebbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"van Poelje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Linemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Erion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"Suppl","key":"R1-13-20260311","first-page":"S186","article-title":"Nonalcoholic fatty liver disease.","volume":"17","author":"Angulo","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"R2-13-20260311","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.","volume":"40","author":"Browning","year":"2004","journal-title":"HEPATOLOGY"},{"key":"R3-13-20260311","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Longterm followup of patients with NAFLD and elevated liver enzymes.","volume":"44","author":"Ekstedt","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R4-13-20260311","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.21391","article-title":"Assessing the outcome of nonalcoholic steatohepatitis? Its time to get serious.","volume":"44","author":"Ratziu","year":"2006","journal-title":"HEPATOLOGY"},{"issue":"Suppl 1","key":"R5-13-20260311","first-page":"S5","article-title":"The epidemiology of nonalcoholic fatty liver disease in adults.","volume":"40","author":"Clark","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"R6-13-20260311","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1111\/j.1572-0241.2006.00719.x","article-title":"Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.","volume":"101","author":"Kang","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R7-13-20260311","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1469-185X.2000.tb00054.x","article-title":"Thyroid hormones and their effects: a new perspective.","volume":"75","author":"Hulbert","year":"2000","journal-title":"Biol Rev Camb Philos Soc"},{"key":"R8-13-20260311","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1210\/jcem.86.11.7981","article-title":"Hepatic lipogenesis and cholesterol synthesis in hyperthyroid patients.","volume":"86","author":"Cachefo","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R9-13-20260311","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1210\/jc.2002-020174","article-title":"Elevated regional lipolysis in hyperthyroidism.","volume":"87","author":"Riis","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-13-20260311","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00054556","article-title":"Cholesterol biosynthesis and metabolism.","volume":"6","author":"Russell","year":"1992","journal-title":"Cardiovasc Drugs Ther"},{"key":"R11-13-20260311","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1210\/en.2003-0973","article-title":"Effects of the thyroid hormone receptor agonist GC1 on metabolic rate and cholesterol in rats and primates: selective actions relative to 3,5,3triiodoLthyronine.","volume":"145","author":"Grover","year":"2004","journal-title":"Endocrinology"},{"key":"R12-13-20260311","doi-asserted-by":"crossref","first-page":"10067","DOI":"10.1073\/pnas.1633737100","article-title":"Selective thyroid hormone receptorbeta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability.","volume":"100","author":"Grover","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R13-13-20260311","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1073\/pnas.0705286104","article-title":"The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans.","volume":"105","author":"Berkenstam","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R14-13-20260311","doi-asserted-by":"crossref","first-page":"15490","DOI":"10.1073\/pnas.0702759104","article-title":"Targeting thyroid hormone receptor agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index.","volume":"104","author":"Erion","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R15-13-20260311","doi-asserted-by":"crossref","first-page":"10297","DOI":"10.1073\/pnas.0504379102","article-title":"Selective thyroid receptor modulation by GC1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice.","volume":"102","author":"Johansson","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R16-13-20260311","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification.","volume":"37","author":"Bligh","year":"1959","journal-title":"Can J Biochem Physiol"},{"key":"R17-13-20260311","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipids from animal tissues.","volume":"226","author":"Folch","year":"1957","journal-title":"J Biol Chem"},{"key":"R18-13-20260311","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1016\/S0021-9258(19)85561-8","article-title":"Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell: apparent translocation of intracellular transport systems to the plasma membrane.","volume":"255","author":"Cushman","year":"1980","journal-title":"J Biol Chem"},{"key":"R19-13-20260311","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1210\/en.2005-1300","article-title":"Atypical expression of type 2 iodothyronine deiodinase in thyrotrophs explains the thyroxinemediated pituitary thyrotropin feedback mechanism.","volume":"147","author":"Christoffolete","year":"2006","journal-title":"Endocrinology"},{"key":"R20-13-20260311","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0090-9556(24)15286-5","article-title":"Metabolism of 3,5,5trimethylhexanoylferrocene by rat liver: release of iron from 3,5,5trimethylhexanoylferrocene by a microsomal, phenobarbitalinducible cytochrome P450.","volume":"27","author":"Cable","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"R21-13-20260311","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0003-2697(84)90011-3","article-title":"A sensitive, continuous spectrophotometric method for assaying alphaglycerophosphate dehydrogenase: activation by menadione.","volume":"139","author":"Garrib","year":"1984","journal-title":"Anal Biochem"},{"key":"R22-13-20260311","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/bj2260183","article-title":"Effects of thyroid hormone on mitochondrial oxidative phosphorylation.","volume":"226","author":"Verhoeven","year":"1985","journal-title":"Biochem J"},{"key":"R23-13-20260311","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-2007-978673","article-title":"A marked upregulation of uncoupling protein 2 gene expression in adipose tissue of hyperthyroid subjects.","volume":"32","author":"Hoffstedt","year":"2000","journal-title":"Horm Metab Res"},{"key":"R24-13-20260311","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000179061","article-title":"Adipose tissue cellularity in hypoand hyperthyroid rats.","volume":"11","author":"Muniesa","year":"1979","journal-title":"Horm Res"},{"key":"R25-13-20260311","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/bj3320361","article-title":"Effect of triiodothyronine on leptin release and leptin mRNA accumulation in rat adipose tissue.","volume":"332","author":"Fain","year":"1998","journal-title":"Biochem J"},{"key":"R26-13-20260311","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1210\/jcem.87.2.8200","article-title":"Regulation of human adipocyte gene expression by thyroid hormone.","volume":"87","author":"Viguerie","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-13-20260311","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0026-0495(77)90101-9","article-title":"Urinary excretion of carnitine in patients with hyperthyroidism and hypothyroidism: augmentation by thyroid hormone.","volume":"26","author":"Maebashi","year":"1977","journal-title":"Metabolism"},{"key":"R28-13-20260311","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/mus.20336","article-title":"Muscle carnitine in hypo and hyperthyroidism.","volume":"32","author":"Sinclair","year":"2005","journal-title":"Muscle Nerve"},{"key":"R29-13-20260311","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1210\/edrv-6-4-590","article-title":"Plasma lipoproteins and regulation of hepatic metabolism of fatty acids in altered thyroid states.","volume":"6","author":"Heimberg","year":"1985","journal-title":"Endocr Rev"},{"key":"R30-13-20260311","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cmet.2005.06.006","article-title":"Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acylCoA:glycerolsn3phosphate acyltransferase 1 knockout mice.","volume":"2","author":"Neschen","year":"2005","journal-title":"Cell Metab"},{"key":"R31-13-20260311","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1210\/en.2006-0116","article-title":"Mouse sterol response element binding protein1c gene expression is negatively regulated by thyroid hormone.","volume":"147","author":"Hashimoto","year":"2006","journal-title":"Endocrinology"},{"key":"R32-13-20260311","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.biochi.2004.11.008","article-title":"Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein1c (SREBP1c): two key regulators of glucose metabolism and lipid synthesis in liver.","volume":"87","author":"Dentin","year":"2005","journal-title":"Biochimie"},{"key":"R33-13-20260311","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0303-7207(95)03509-6","article-title":"Tissuespecific regulation of lipogenic mRNAs by thyroid hormone.","volume":"110","author":"Blennemann","year":"1995","journal-title":"Mol Cell Endocrinol"},{"key":"R34-13-20260311","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1194\/jlr.M400479-JLR200","article-title":"ApoCIII deficiency prevents hyperlipidemia induced by apoE overexpression.","volume":"46","author":"Gerritsen","year":"2005","journal-title":"J Lipid Res"},{"key":"R35-13-20260311","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nm1051","article-title":"3Iodothyronamine is an endogenous and rapidacting derivative of thyroid hormone.","volume":"10","author":"Scanlan","year":"2004","journal-title":"Nat Med"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.22572","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200902000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T18:02:58Z","timestamp":1773252178000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200902000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.22572","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}